Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Endocrine Testing Market, and What Factors Will Drive It?
In recent times, there has been a significant escalation in the endocrine testing market. The projection suggests an expansion from $2.55 billion in 2024 to $2.79 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this increase during the historical duration include the identification of hormones and endocrine routes, standardization of diagnostic tests, implementation of public health strategies, and elevated patient advocacy and autonomy.
The size of the endocrine testing market is predicted to increase significantly in the upcoming years, reaching$3.89 billion by 2029″ with a compound annual growth rate of 8.7%. The spike in the predicted period can be ascribed to the rising occurrence of endocrine disorders, enhanced defense expenditure, aging demographic, awareness and early diagnostics, along with an escalated consciousness. Predominant trends expected during the forecast period are progress in biomarker detection, amalgamation of omics technologies, the application of artificial intelligence and machine learning, assured quality and standardization, and cooperative research along with translational medicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp
Which Factors and External Forces Are Driving Demand in the Endocrine Testing Market?
The burgeoning occurrence of diabetes is predicted to accelerate the expansion of the endocrine testing market in the future. Diabetes is a cluster of disorders characterized by elevated blood sugar or glucose levels. The increase in diabetes cases can be attributed to unhealthy eating habits, lack of physical activity, genetic factors, and an aging demographic. Various endocrine tests like hemoglobin A1c, fasting plasma glucose, and C-peptide tests are utilized in diagnosing diabetes, maintaining a check on glucose levels, and evaluating insulin production and response. For example, in June 2024, as per the National Health Service (NHS), a UK government department, there was a rise seen in individuals below 40 years, from 173,166 in 2022 to 216,440 in 2023. This marked increase signifies a worrying trend in this age bracket, indicating a quick surge in diabetes incidence among the younger generations. Consequently, the growing prevalence of diabetes is fueling the growth of the endocrine testing market.
Which Segments in the Endocrine Testing Offer the Most Growth?
The endocrine testingmarket covered in this report is segmented –
1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
Subsegments:
1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15562&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Endocrine Testing Market?# Market?
North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theEndocrine Testing Market’s Growth?
Leading firms in the endocrine testing market are innovating point-of-care testing methods to increase the ease and effectiveness of identifying endocrine disorders. Quick results provided by point-of-care testing can assist in swiftly diagnosing and managing heart failure in patients showing symptoms like fatigue and breathlessness. For example, Roche Holding AG, a pharmaceutical corporation based in Switzerland, introduced a point-of-care NT-proBNP diagnostic test in India in April 2024. This was specifically tailored for screening diabetes patients at risk of heart-related ailments, such as heart failure (HF). The test makes early detection and treatment possible, allowing doctors to pinpoint patients with high-risk T2D and begin prompt discussions for treatment. The implementation of this test ultimately aids in promoting better patient health outcomes and well-being.
View the full report here:
https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report
What Are the Key Elements That Define the Endocrine Testing Market?
Endocrine testing refers to the diagnostic process of evaluating hormone levels in the body, typically through blood, urine, or saliva tests, to assess the function of the endocrine system. These tests are crucial for diagnosing various endocrine disorders, including diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders. Endocrine testing helps healthcare providers determine the appropriate treatment and management plans for patients with these conditions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15562
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
